The patterns of response of 11 regimens for infantile spasms

Leilei Mao1, Miriam Kessi1, Pan Peng1

  • 1Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.

Scientific Reports
|July 15, 2020
PubMed

Insights

Early treatment of infantile spasms (ISs) with first-line therapies significantly improves seizure freedom rates. Delaying these treatments reduces their effectiveness, highlighting the importance of timely intervention for this epilepsy form.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Therapeutics

Background:

  • Infantile spasms (ISs) represent a severe form of early infantile epileptic encephalopathy.
  • Optimal treatment strategies and the impact of treatment timing on outcomes remain incompletely understood.

Purpose of the Study:

  • To investigate the response patterns of various therapeutic regimens in infantile spasms.
  • To compare seizure freedom rates between patients receiving early versus delayed first-line therapies.

Main Methods:

  • Retrospective analysis of 314 infantile spasms cases.
  • Evaluation of the efficacy of 11 different treatment regimens.
  • Comparison of outcomes based on the timing of first-line therapy administration.

Main Results:

  • The efficacy of sequential regimens showed diminishing returns: first two regimens (36.99%), third (10.27%), fourth (6.16%), fifth (5.48%).
  • Regimens from the sixth onwards added less than 2% probability of seizure freedom each.
  • A statistically significant difference in seizure freedom was observed favoring early administration of first-line therapies.

Conclusions:

  • Seizure freedom in infantile spasms is most likely achieved within the first five treatment regimens.
  • Early administration of first-line therapies is demonstrably superior to initiating treatment with non-first-line options.
  • Findings support timely initiation of first-line treatments for improved infantile spasms management.

Related Concept Videos

Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.2K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.9K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
795
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.1K
Somatic Spinal Reflexes01:22

Somatic Spinal Reflexes

Somatic spinal reflexes are rapid, involuntary muscular responses to external stimuli that involve the somatic musculature and the spinal cord.
One of the most well-known somatic spinal reflexes is the stretch reflex, which is activated by the sudden stretching of a muscle. This reflex involves the activation of specialized sensory receptors called muscle spindles, which are located in the muscle tissue and detect changes in the length and speed of muscle contractions. When a muscle is suddenly...
4.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
699